In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews, April 2012

Executive Summary

This Month's Profile Group, Vaccine Investment Gets A Shot In The Arm, features profiles of Genocea Biosciences, Imaxio, Selecta Biosciences and TremRx. Plus these Start-Ups Across Health Care: Bluegrass Vascular Technologies, Haldor Advanced Technologies and Targovax.

You may also be interested in...

Haldor Advanced Technologies Ltd.

Haldor Advanced Technologies Ltd.’s ORLocate surgical instrument tracking and asset management system uses RFID to automatically track, trace, monitor and manage the life cycle of instruments and consumables within the hospital – before, during and after a surgical procedure. In addition to managing the logistical chain and the specific location of an instrument at any point in time, ORLocate is designed to be a comprehensive workflow management system that provides statistical and processing data, par-level and inventory management and preventive maintenance.

Bluegrass Vascular Technologies Inc.

Central venous catheters are commonly employed to deliver long-term dialysis, nutrition and chemotherapy, but nearly 10% of patients have an upper-extremity venous occlusion that renders the vein impenetrable by standard access techniques. When access is not possible through traditional “outside-in” routes, Bluegrass Vascular Technologies’ Surfacer system allows for central venous access through the femoral vein in the leg. The device features a bullet-shaped catheter tip with a proprietary side-exit needle that allows the physician to enter into the occlusion and create a new tissue channel, from the inside out.

In Vivo's Deals Of The Month, February 2018

In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts